Poitou C, Viguerie N, Cancello R, De Matteis R, Cinti S, Stich V, Coussieu C, Gauthier E, Courtine M, Zucker J D, Barsh G S, Saris W, Bruneval P, Basdevant A, Langin D, Clément K
Department of Nutrition and Biochemistry, French Institute of Health and Medical Research Avenir, EA 3502, Paris VI University, Hôtel-Dieu Hospital, Paris, France.
Diabetologia. 2005 Mar;48(3):519-28. doi: 10.1007/s00125-004-1654-6. Epub 2005 Feb 24.
AIMS/HYPOTHESIS: The acute-phase proteins, serum amyloid As (SAA), are precursors of amyloid A, involved in the pathogenesis of AA amyloidosis. This work started with the characterisation of systemic AA amyloidosis concurrent with SAA overexpression in the subcutaneous white adipose tissue (sWAT) of an obese patient with a leptin receptor deficiency. In the present study a series of histopathological, cellular and gene expression studies was performed to assess the importance of SAA in common obesity and its possible production by mature adipocytes.
Gene expression profiling was performed in the sWAT of two extremely obese patients with a leptin receptor deficiency. Levels of the mRNAs of the different SAA isoforms were quantified in sWAT cellular fractions from lean subjects and from obese subjects before and after a very-low-calorie diet. These values were subsequently compared with serum levels of SAA in these individuals. In addition, histopathological analyses of sWAT were performed in lean and obese subjects.
In sWAT, the expression of SAA is more than 20-fold higher in mature adipocytes than in the cells of the stroma vascular fraction (p<0.01). Levels of SAA mRNA expression and circulating levels of the protein are sixfold (p<0.001) and 3.5-fold (p<0.01) higher in obese subjects than in lean subjects, respectively. In lean subjects, 5% of adipocytes are immunoreactive for SAA, whereas the corresponding value is greater than 20% in obese subjects. Caloric restriction results in decreases of 45-75% in levels of the transcripts for the SAA isoforms and in circulating levels of the protein.
CONCLUSIONS/INTERPRETATION: The results of the present study indicate that SAA is expressed by sWAT, and its production at this site is regulated by nutritional status. If amyloidosis is seen in the context of obesity, it is possible that production of SAA by adipocytes could be a contributory factor.
目的/假设:急性期蛋白血清淀粉样蛋白A(SAA)是淀粉样蛋白A的前体,参与AA型淀粉样变性的发病机制。这项研究始于对一名患有瘦素受体缺乏症的肥胖患者皮下白色脂肪组织(sWAT)中系统性AA型淀粉样变性并发SAA过表达的特征描述。在本研究中,进行了一系列组织病理学、细胞和基因表达研究,以评估SAA在普通肥胖中的重要性及其可能由成熟脂肪细胞产生的情况。
对两名患有瘦素受体缺乏症的极度肥胖患者的sWAT进行基因表达谱分析。在低脂饮食前后,对瘦素受体缺乏症患者、肥胖患者sWAT细胞组分中不同SAA亚型的mRNA水平进行定量。随后将这些值与这些个体的血清SAA水平进行比较。此外,对瘦素受体缺乏症患者、肥胖患者的sWAT进行组织病理学分析。
在sWAT中,成熟脂肪细胞中SAA的表达比基质血管部分的细胞高20倍以上(p<0.01)。肥胖受试者中SAA mRNA表达水平和蛋白质循环水平分别比瘦素受体缺乏症患者高6倍(p<0.001)和3.5倍(p<0.01)。在瘦素受体缺乏症患者中,5%的脂肪细胞对SAA呈免疫反应,而在肥胖受试者中相应值大于20%。热量限制导致SAA亚型转录水平和蛋白质循环水平降低45-75%。
结论/解读:本研究结果表明,SAA由sWAT表达,其在该部位的产生受营养状况调节。如果在肥胖背景下出现淀粉样变性,脂肪细胞产生SAA可能是一个促成因素。